日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

T-cell immune checkpoint inhibition plus hypomethylation for locally advanced HER2-negative breast cancer: a phase 2 neoadjuvant window trial of decitabine and pembrolizumab followed by standard neoadjuvant chemotherapy

T细胞免疫检查点抑制剂联合低甲基化治疗局部晚期HER2阴性乳腺癌：一项地西他滨联合帕博利珠单抗序贯标准新辅助化疗的II期新辅助窗口期试验

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.3
doi:10.1136/jitc-2024-010294
Harry D Bear ，Xiaoyan Deng ，Dipankar Bandyopadhyay ，Michael Idowu ，Taylor M Jenkins ，Maciej Kmieciak ，Monique Williams ，Giovanni Archer ，Lindsey Gwaltney ，Patrick Dillon ，Daniel Flora ，Daniel Stover ，Andrew S Poklepovic ，Mary Hackney ，Masey Ross ，Hetal Vachhani ，Raphael Louie ，Kandace P McGuire ，Amelia Grover ，Tasnim Rahman ，Amber Hendrix
免疫/内分泌
乳腺癌
Checkpoint
T细胞
发表日期：2025
文献求助 收藏

Aromatase inhibitor associated arthralgia: the importance of oncology provider-patient communication about side effects and potential management through physical activity

芳香化酶抑制剂相关性关节痛：肿瘤科医生与患者就副作用及通过体育活动进行潜在管理进行沟通的重要性

期刊:Supportive Care in Cancer
影响因子:3
doi:10.1007/s00520-015-3065-2
Nyrop, Kirsten A; Callahan, Leigh F; Rini, Christine; Altpeter, Mary; Hackney, Betsy; DePue, Amy; Wilson, Anne; Schechter, Arielle; Muss, Hyman B
肿瘤
肿瘤免疫
发表日期：2016
文献求助 收藏

Adaptation of an Evidence-Based Arthritis Program for Breast Cancer Survivors on Aromatase Inhibitor Therapy Who Experience Joint Pain

针对接受芳香化酶抑制剂治疗且出现关节疼痛的乳腺癌幸存者，调整循证关节炎治疗方案

期刊:Preventing Chronic Disease
影响因子:3.9
doi:10.5888/pcd12.140535
Nyrop, Kirsten A; Callahan, Leigh F; Rini, Christine; Altpeter, Mary; Hackney, Betsy; Schecher, Arielle; Wilson, Anne; Muss, Hyman B
关节炎
肿瘤
肿瘤免疫
乳腺癌
发表日期：2015
文献求助 收藏